Sales Performance - Sales for the three months ended March 31, 2024, decreased by approximately 16% to 336.8millioncomparedto400.5 million in the prior year period, primarily due to unfavorable market-based pricing and a decrease in sales volume [80]. - The decrease in sales volume was approximately 6.7%, driven by lost sales resulting from an operational disruption at the Frankford, Pennsylvania manufacturing site [80]. - Sales for the three months ended March 31, 2024, were 336.8million,comparedto400.5 million for the same period in 2023, reflecting a decline of approximately 15.9% [89]. Financial Results - The Company's net income (loss) for the three months ended March 31, 2024, was (17.4)million,adecreasefrom35.0 million in the same period of 2023 [86]. - Adjusted EBITDA for the three months ended March 31, 2024, was 595thousand,significantlydownfrom65.4 million in the prior year period [89]. - The adjusted net income (loss) for the three months ended March 31, 2024, was (15.1)million,comparedto37.1 million in the same period of 2023 [89]. - The adjusted EBITDA margin for the three months ended March 31, 2024, was 0.2%, a significant decrease from 16.3% in the prior year [89]. Costs and Expenses - Costs of goods sold increased by approximately 1% to 333.9million,influencedbylowerproductionvolumesandincrementalcostsfromtheoperationaldisruption[81].−Grossmarginpercentagedecreasedtoapproximately0.91.5 million to 23.6million,representing7.027 million due to lost sales and additional costs [79]. - The company aims to run its production facilities continuously for maximum efficiency, although this exposes it to risks associated with material disruptions [78]. Capital Expenditures and Cash Flow - The Company expects capital expenditures to be between 140millionand150 million in 2024, an increase from 107millionin2023[95].−Cashprovidedbyoperatingactivitiesdecreasedby37.8 million for the three months ended March 31, 2024, primarily due to a 52.4milliondecreaseinnetincome[110].−Cashusedforinvestingactivitiesincreasedby11.2 million for the three months ended March 31, 2024, mainly due to capital expenditures of approximately 10.8million[111].DebtandCreditFacilities−TheCompanycompletedarefinancingofitsCreditAgreement,establishinganewseniorsecuredrevolvingcreditfacilitywithanaggregateprincipalamountof500 million [104]. - As of March 31, 2024, the Company had a borrowed balance of 245millionundertheRevolvingCreditFacility,withavailablecreditofapproximately254 million [109]. - The Credit Agreement requires the Company to maintain a Consolidated Interest Coverage Ratio of not less than 3.00 to 1.00 and a Consolidated Leverage Ratio of 4.00 to 1.00 or less until September 30, 2023 [108]. - The Company has the option to increase the Revolving Credit Facility by up to 175million,subjecttomaintainingaConsolidatedFirstLienSecuredLeverageRatioofnotgreaterthan2.75to1.00[105].−ThetransitionfromLIBORtoAdjustedTermSOFRasthebenchmarkratewaseffectiveJuly1,2023,withapplicablemarginssetat0.25189.0 million at a weighted average price of 30.94pershare[98].−TheCompanydeclareddividendsof0.160 per share for the periods ending May 28, 2024, and March 18, 2024, totaling approximately 4.3millioneach[102].Taxation−TheeffectivetaxrateforthethreemonthsendedMarch31,2024,was25.70.6 million for the three months ended March 31, 2024 [116].